Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Martin regarded DDAVP of limited value and difficult to use with small children. He made a conscious decision not to use it despite its availability within his hospital.

  • Read more about Dr Martin regarded DDAVP of limited value and difficult to use with small children. He made a conscious decision not to use it despite its availability within his hospital.

Dr Martin did not attend any UKHCDO meetings in the 1970s and 1980s by his own choice.

  • Read more about Dr Martin did not attend any UKHCDO meetings in the 1970s and 1980s by his own choice.

Dr Martin had no recollection of the 24 June 1983 letter from Professor Bloom and Dr Rizza but accepted that there was no alteration in the treatment regime at the time.

  • Read more about Dr Martin had no recollection of the 24 June 1983 letter from Professor Bloom and Dr Rizza but accepted that there was no alteration in the treatment regime at the time.

Dr Martin did not regard the risk of hepatitis as reason to alter any treatment regime. His aim was however to "keep children out of hospital as much as possible"

  • Read more about Dr Martin did not regard the risk of hepatitis as reason to alter any treatment regime. His aim was however to "keep children out of hospital as much as possible"

Dr Martin described how there was no instruction to use cryoprecipitate on milder haemophiliacs and that it was generally phased out in the early 1980s.

  • Read more about Dr Martin described how there was no instruction to use cryoprecipitate on milder haemophiliacs and that it was generally phased out in the early 1980s.

Dr Martin said that his treatment of the child with concentrate was consistent with the standard treatment being given to patients at the time

  • Read more about Dr Martin said that his treatment of the child with concentrate was consistent with the standard treatment being given to patients at the time

The second report relating to Stephen's treatment, prepared by Dr Ludlam, noted if cryoprecipitate was not available, then NHS concentrate would be the most appropriate therapy and queried Royal Liverpool Hospital policy

  • Read more about The second report relating to Stephen's treatment, prepared by Dr Ludlam, noted if cryoprecipitate was not available, then NHS concentrate would be the most appropriate therapy and queried Royal Liverpool Hospital policy

Dr Martin's treatment of Stephen was not atypical, it was also practiced where his brother was treated with commercial concentrates from the age of two

  • Read more about Dr Martin's treatment of Stephen was not atypical, it was also practiced where his brother was treated with commercial concentrates from the age of two

A child treated was with concentrates from 1978 onwards and records failed to identify the type of batch number.

  • Read more about A child treated was with concentrates from 1978 onwards and records failed to identify the type of batch number.

A DHSS analysis of legal claims acknowledged it would be indefensible if any commercial concentrate given in 1985 was not heat-treated.

  • Read more about A DHSS analysis of legal claims acknowledged it would be indefensible if any commercial concentrate given in 1985 was not heat-treated.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Current page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.